These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 15365540
1. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis. Stokes M, Amorosi SL, Thompson D, Dupclay L, Garcia J, Georges G. Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540 [Abstract] [Full Text] [Related]
2. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Bachert C, El-Akkad T. Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650 [Abstract] [Full Text] [Related]
3. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis. Khanna P, Shah A. Am J Rhinol; 2005 Sep; 19(3):316-21. PubMed ID: 16011141 [Abstract] [Full Text] [Related]
4. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study. Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE. Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265 [Abstract] [Full Text] [Related]
5. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study. Meltzer EO, Andrews C, Journeay GE, Lim J, Prillaman BA, Garris C, Philpot E. Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344 [Abstract] [Full Text] [Related]
6. Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis. Gross G, Jacobs RL, Woodworth TH, Georges GC, Lim JC. Ann Allergy Asthma Immunol; 2002 Jul; 89(1):56-62. PubMed ID: 12141721 [Abstract] [Full Text] [Related]
10. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Mahadevia PJ, Shah S, Leibman C, Kleinman L, O'Dowd L. Ann Allergy Asthma Immunol; 2004 Oct; 93(4):345-50. PubMed ID: 15521370 [Abstract] [Full Text] [Related]
13. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis. Mak KK, Ku MS, Lu KH, Sun HL, Lue KH. Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528 [Abstract] [Full Text] [Related]
14. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA. Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285 [Abstract] [Full Text] [Related]
15. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis. Yonezaki M, Akiyama K, Karaki M, Goto R, Inamoto R, Samukawa Y, Kobayashi R, Kobayashi E, Hoshikawa H. Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699 [Abstract] [Full Text] [Related]